Perceptive Advisors’s Exact Sciences EXAS Stock Holding History

Perceptive Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-200,000	Closed	-$670K	–	177
2016 Q4	$670K	Buy	+200,000	New	+$3.23M	0.05%	104
2014 Q2	–	Sell	-900,000	Closed	-$12.8M	–	129
2014 Q1	$12.8M	Buy	+900,000	New	+$12.2M	1.34%	23

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Perceptive Advisors's EXAS Position: Q1 2026 in Review

Perceptive Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,200,487 shares — an estimated $122M sold.

Perceptive Advisors first reported a position in EXAS in Q2 2013 and held it in 13 quarters. The position peaked at $122M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Perceptive Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Perceptive Advisors sold 1,200,487 Exact Sciences shares in Q1 2026, an estimated $122M.
Perceptive Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 13 quarters.
Perceptive Advisors's Exact Sciences position peaked at $122M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.